Fifth Third Bancorp’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63K | Buy |
25
+10
| +67% | +$652 | ﹤0.01% | 2373 |
|
|
2025
Q1 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 2395 |
|
|
2024
Q4 | – | Sell |
-12
| Closed | -$716 | – | 2513 |
|
|
2024
Q3 | $716 | Buy |
+12
| New | +$716 | ﹤0.01% | 2480 |
|
|
2024
Q2 | – | Sell |
-2
| Closed | -$138 | – | 2451 |
|
|
2024
Q1 | $138 | Buy |
+2
| New | +$138 | ﹤0.01% | 2351 |
|
|
2022
Q2 | – | Sell |
-4
| Closed | – | – | 2639 |
|
|
2022
Q1 | $0 | Sell |
4
-78
| -95% | – | ﹤0.01% | 2661 |
|
|
2021
Q4 | $4K | Buy |
82
+78
| +1,950% | +$3.81K | ﹤0.01% | 2375 |
|
|
2021
Q3 | $0 | Sell |
4
-96
| -96% | – | ﹤0.01% | 2636 |
|
|
2021
Q2 | $4K | Buy |
+100
| New | +$4K | ﹤0.01% | 2227 |
|
|
2020
Q1 | – | Sell |
-5,832
| Closed | -$360K | – | 2114 |
|
|
2019
Q4 | $360K | Buy |
5,832
+1,020
| +21% | +$63K | ﹤0.01% | 753 |
|
|
2019
Q3 | $351K | Sell |
4,812
-133
| -3% | -$9.7K | ﹤0.01% | 744 |
|
|
2019
Q2 | $406K | Sell |
4,945
-1,550
| -24% | -$127K | ﹤0.01% | 686 |
|
|
2019
Q1 | $458K | Sell |
6,495
-807
| -11% | -$56.9K | ﹤0.01% | 628 |
|
|
2018
Q4 | $329K | Sell |
7,302
-2,648
| -27% | -$119K | ﹤0.01% | 724 |
|
|
2018
Q3 | $563K | Buy |
9,950
+172
| +2% | +$9.73K | ﹤0.01% | 659 |
|
|
2018
Q2 | $653K | Sell |
9,778
-454
| -4% | -$30.3K | ﹤0.01% | 616 |
|
|
2018
Q1 | $596K | Buy |
10,232
+1,559
| +18% | +$90.8K | ﹤0.01% | 620 |
|
|
2017
Q4 | $559K | Sell |
8,673
-574
| -6% | -$37K | ﹤0.01% | 661 |
|
|
2017
Q3 | $485K | Sell |
9,247
-233
| -2% | -$12.2K | ﹤0.01% | 679 |
|
|
2017
Q2 | $444K | Sell |
9,480
-1,370
| -13% | -$64.2K | ﹤0.01% | 719 |
|
|
2017
Q1 | $537K | Buy |
10,850
+2,424
| +29% | +$120K | ﹤0.01% | 684 |
|
|
2016
Q4 | $511K | Sell |
8,426
-648
| -7% | -$39.3K | ﹤0.01% | 714 |
|
|
2016
Q3 | $602K | Buy |
+9,074
| New | +$602K | 0.01% | 677 |
|